BlueCrest Capital Management »

Atrium Therapeutics shares owned by BlueCrest Capital Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by BlueCrest Capital Management from 13F filings

Historical chart of BlueCrest Capital Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by BlueCrest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by BlueCrest Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 100k 13.45

More positions owned by BlueCrest Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Spdr Series Trust St Str P500etf (SPYM)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Vaneck Etf Trust Semiconductr Etf (SMH)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Micron Technology (MU)
Echostar Corp Cl A
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf Put Option (BKLN)
Zoom Communications Cl A (ZM)
Jazz Investments I Note 3.125% 9/1 (Principal)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Criteo S A Spons Ads (CRTO)

View all positions for BlueCrest Capital Management

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
State Street Corporation
Cantor Fitzgerald, L. P.
Slotnik Capital

View all funds holding Atrium Therapeutics